Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
CNS Neuroscience and Therapeutics is Scopus-indexed (Q1, CiteScore 8.5), WoS SCIE, DOAJ. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 1755-5930Verify ISSN ↗1755-5949Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Psychiatry and Mental Health | 55 / 580 | 90th | Q1 |
| Pharmacology (medical) | 32 / 278 | 88th | Q1 |
| Physiology (medical) | 19 / 117 | 84th | Q1 |
| Pharmacology | 54 / 328 | 83rd | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q1, CiteScore 8.5.
CNS Neuroscience and Therapeutics is Q1 in Psychiatry and Mental Health (rank 55 of 580), Q1 in Pharmacology (medical) (rank 32 of 278) and Q1 in Physiology (medical) (rank 19 of 117), by CiteScore 2025. It is ranked in 4 subject areas in all.
CNS Neuroscience and Therapeutics is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 8.5, which places it in quartile Q1 at the 90th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.741, quartile Q1, with an H-index of 105.
The publisher lists an article processing charge of about US$4,140 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
CNS Neuroscience and Therapeutics is published by John Wiley and Sons Inc. Its print ISSN is 1755-5930 and its online ISSN is 1755-5949.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
CNS Neuroscience and Therapeutics has an h-index of 121 and a 2-year mean of 6.04 citations per paper (OpenAlex). Its Scopus CiteScore is 8.5, quartile Q1. On 2-year citations it ranks #29 of 570 Scopus journals in Psychiatry and Mental Health.
CNS Neuroscience and Therapeutics published 560 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from China (82.8%), United States (5.1%) and Iran (2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 17 retracted papers are recorded (4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.